Telix Pharmaceuticals
Sm‑TLX090‑101
Phase I bone pain theranostic study.
Precision Medicine from Discovery to Recovery. NovaCure is a South Florida clinical research platform focused on radiopharmaceutical and theranostic trials, supporting pharmaceutical sponsors, investigators, and referring physicians.
NovaCure supports the execution of targeted radiopharmaceutical and theranostic clinical trials through a coordinated research model built around imaging access, oncology collaboration, and site operations.
To help advance precision oncology by enabling practical, high-quality clinical research access for innovative molecular imaging and radioligand therapy programs.
A focused clinical research environment for targeted imaging, therapy development, and radiopharmaceutical trial execution.
Support for diagnostic, therapeutic, and paired diagnostic-therapy programs across oncology indications.
Integration with PET/CT, SPECT/CT, quantitative imaging, and imaging-based trial workflows.
Coordination with referring physicians and oncology networks to support appropriate trial identification.
Current NovaCure priority studies are presented below for sponsor, investigator, and physician awareness. Trial participation depends on protocol-specific eligibility criteria.
Sm‑TLX090‑101
Phase I bone pain theranostic study.
BET‑PSMA‑121
Phase I/II mCRPC radioligand therapy study.
Lu‑TLX591‑203
Oncology / metastatic castration-resistant prostate cancer radioligand therapy study.
First‑in‑Human RLT Study
Phase I targeted radioligand therapy study.
NovaCure is positioned for sponsor partnerships requiring theranostic expertise, rapid coordination, and oncology-focused clinical research execution.
Protocol startup coordination, research documentation, and support.
Coordinator-led trial workflows, scheduling support, and study visit management.
Access to molecular imaging workflows that support oncology and theranostic endpoints.
NovaCure collaborates with oncologists, urologists, nuclear medicine physicians, and specialists to identify appropriate research opportunities for eligible patients.
Clear visibility into active and upcoming studies.
Direct communication with the research coordinator.
Physician-to-site collaboration around protocol requirements.
Prostate cancer, radioligand therapy, targeted imaging, precision oncology, and theranostic clinical trial referrals.
amunguia@novacurehealth.com
(786) 485-0770
9408 SW 87th Ave, Suite 104
Miami, FL 33176
Clinical research partnerships, sponsor inquiries, and physician collaboration opportunities.